Search

Your search keyword '"Ghazinyan, H"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Ghazinyan, H" Remove constraint Author: "Ghazinyan, H"
34 results on '"Ghazinyan, H"'

Search Results

1. A global research priority agenda to advance public health responses to fatty liver disease

2. Global multi-stakeholder endorsement of the MAFLD definition

3. Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy

4. Advancing the global public health agenda for NAFLD: a consensus statement

5. Etiology, time frame and spectrum of decompensation in 6236 patients of cirrhosis liver across Asia: a multinational study from APASL ACLF Research Consortium (AARC)

6. Portal Hemodynamics Predicts the Outcome in Severe Alcoholic Hepatitis Presenting as Acute-on-Chronic Liver Failure

7. Better Survival in Patients with Hepatitis E Virus C.F. to Other Acute Insults Causing Acute-on-Chronic Liver Failure (ACLF) – APASL-ACLF Research Consortium (AARC) Database

8. The Decision for Liver Transplant in Acute on Chronic Liver Failure (ACLF) - First Week is the Crucial Period - Analysis of the Apasl ACLF Research Consortium (AARC) Prospective Data of 1021 Patients

9. Acute on Chronic Liver Failure Secondary to Drugs: Causes, Outcome and Predictors of Mortality

10. THU-107 - Better Survival in Patients with Hepatitis E Virus C.F. to Other Acute Insults Causing Acute-on-Chronic Liver Failure (ACLF) – APASL-ACLF Research Consortium (AARC) Database

11. THU-384 - Portal Hemodynamics Predicts the Outcome in Severe Alcoholic Hepatitis Presenting as Acute-on-Chronic Liver Failure

13. PS033 - The Decision for Liver Transplant in Acute on Chronic Liver Failure (ACLF) - First Week is the Crucial Period - Analysis of the Apasl ACLF Research Consortium (AARC) Prospective Data of 1021 Patients

16. Advancing the global public health agenda for NAFLD: a consensus statement

17. Global multi-stakeholder endorsement of the MAFLD definition

18. Global multi-societies endorsement of the MAFLD definition.

19. Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease-Related Acute-on-Chronic Liver Failure.

20. An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease.

22. Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition.

23. Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients.

24. An international multidisciplinary consensus statement on MAFLD and the risk of CVD.

25. Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy.

26. 'First week' is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure.

27. Assessment of pathomorphological characteristics of the oral mucosa in patients with HBV, HCV and HIV.

28. Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure.

29. Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

30. Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy.

31. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

32. Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study.

33. Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure.

34. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

Catalog

Books, media, physical & digital resources